Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback